PubMed=8010779; DOI=10.1016/0003-4975(94)90090-6
Smythe W.R., Kaiser L.R., Hwang H.C., Amin K.M., Pilewski J.M., Eck S.L., Wilson J.M., Albelda S.M.
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.
Ann. Thorac. Surg. 57:1395-1401(1994)

PubMed=8174104
Smythe W.R., Hwang H.C., Amin K.M., Eck S.L., Davidson B.L., Wilson J.M., Kaiser L.R., Albelda S.M.
Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Cancer Res. 54:2055-2059(1994)

PubMed=12063468; DOI=10.1067/mtc.2002.121684
Smythe W.R., Mohuiddin I., Ozveran M., Cao X.-B.
Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.
J. Thorac. Cardiovasc. Surg. 123:1191-1198(2002)

PubMed=12707267; DOI=10.1074/jbc.M302161200
Vivo C., Liu W.-H., Broaddus V.C.
c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
J. Biol. Chem. 278:25461-25467(2003)

PubMed=18223230; DOI=10.1158/1078-0432.CCR-07-1388
Bertino P., Piccardi F., Porta C., Favoni R.E., Cilli M., Mutti L., Gaudino G.
Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts.
Clin. Cancer Res. 14:541-548(2008)

PubMed=22552293; DOI=10.1158/0008-5472.CAN-11-3481; PMCID=PMC3389268
Jube S., Rivera Z.S., Bianchi M.E., Powers A., Wang E., Pagano I., Pass H.I., Gaudino G., Carbone M., Yang H.-N.
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
Cancer Res. 72:3290-3301(2012)